Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Asia Pacific Drug Development Market: By Mode: In House, Outsourced; By Process Step: Process Research Development, Formulation, Analytical & Stability Studies, Others; By Therapeutic Area; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Asia Pacific Drug Development Market Outlook

The Asia Pacific drug development market reached USD 38.23 billion in 2020 and is projected to grow at a CAGR of 7.1% over the 2021-2026 forecast period.

 

Asia Pacific Drug Development Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The changing market dynamics, such as the constant growth of the pharmerging market, coupled with the saturated growth rates in established markets, are driving the growth of the drug development market in the Asia Pacific. Also, capital inflows from the western region in the Asian pharmaceutical industry offer substantial opportunities for business expansion to new entrants.

 

Properties and Applications

Drug development is the method of developing a new drug once a lead compound has been discovered through the drug discovery method. The Asia Pacific drug development industry can be divided on the basis of segments like mode, process step, and therapeutic area.

 

Asia Pacific Drug Development Market By Mode

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry can be broadly categorised based on mode into:

  • In House
  • Outsourced

The industry can be divided on the basis of process step as:

  • Process Research Development
  • Formulation
  • Analytical and Stability Studies
  • Drug Metabolism and Pharmacokinetics (DMPK)
  • Safety Assessment (Toxicology)
  • Regulatory Compliance
  • Packaging

The industry can be divided based on the therapeutic area:

  • Oncology
  • Inflammation and Immunology
  • Cardiology            
  • Neuroscience
  • Others

The EMR report looks into the Asia Pacific drug development markets like India, Japan, and China.

 

Asia Pacific Drug Development Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Regulatory authorities such as the China Food and Drug Administration have made significant improvements in addressing critical system gaps. These are working to provide the basis for enhancing the registration process and driving developments in the drug development market in the Asia Pacific in order to stimulate growth. In the clinical trials, companies have efficiently shifted from giving a value proposition based on "speed and cost" to value-added proposals. It involves the transition from early-stage licensing to later stage licensing for growth. However, the trend for business model charges, as well as risk-sharing and collaborations, are being adopted. The rise in new product launches depicts the remarkable growth within the Asia Pacific drug development industry. The cost-saving advantages of the Asian market have prompted global companies to integrate Asia into its global framework for drug development. However, to some degree, the existence of some constraints in the area is anticipated to hinder growth. One of these problems is that the study promoters have to pay the cost of studies and research in Asia, whereas insurance providers and government payers in the western countries make payments throughout the trial for the general healthcare costs of enrolled patients. Nevertheless, the average cost of running studies in the Asia Pacific is significantly lower than in the West, thus, reducing the impact of this constraint.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the Asia Pacific drug development market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Samsung BioLogics 
  • WuXi Biologics 
  • Celltrion Inc. 
  • PT Kalbe Farma Tbk
  • Eurofins Advinus
  • Covance Inc.
  • Celerion Inc.
  • Parexel International Corporation 
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Asia Pacific Drug Development Market Analysis
    6.1    Asia Pacific Drug Development Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Asia Pacific Drug Development Market Breakup by Mode
        6.2.1    In House
        6.2.2    Outsourced
    6.3     Asia Pacific Drug Development Market Breakup by Mode: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    In House
        6.3.2    Outsourced
    6.4    Asia Pacific Drug Development Market by Process Step
        6.4.1    Process Research Development
        6.4.2    Formulation
        6.4.3    Analytical & Stability Studies
        6.4.4    Drug Metabolism and Pharmacokinetics (DMPK)
        6.4.5    Safety Assessment (Toxicology)
        6.4.6    Regulatory Compliance
        6.4.7    Packaging
    6.5    Asia Pacific Drug Development Market by Process Step: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    Process Research Development
        6.5.2    Formulation
        6.5.3    Analytical & Stability Studies
        6.5.4    Drug Metabolism and Pharmacokinetics (DMPK)
        6.5.5    Safety Assessment (Toxicology)
        6.5.6    Regulatory Compliance
        6.5.7    Packaging
    6.6    Asia Pacific Drug Development Market by Therapeutic Area
        6.6.1    Oncology
        6.6.2    Inflammation & Immunology
        6.6.3    Cardiology             
        6.6.4    Neuroscience
        6.6.5    Others 
    6.7    Asia Pacific Drug Development Market by Therapeutic Area: Historical Market (2016-2020) & Forecast (2021-2026)
        6.7.1    Oncology
        6.7.2    Inflammation & Immunology
        6.7.3    Cardiology             
        6.7.4    Neuroscience
        6.7.5    Others 
    6.8    Asia Pacific Drug Development Market Breakup by Region
        6.8.1    India
        6.8.2    Japan
        6.8.3    China
    6.9    Asia Pacific Drug Development Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.9.1    India
        6.9.2    Japan
        6.9.3    China 
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis
    9.1    Samsung BioLogics (207940 (KRX))
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    WuXi Biologics (2269 (HKG))
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Celltrion Inc. (068270 (KRX))
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    PT Kalbe Farma Tbk
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Eurofins Advinus
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Covance Inc.
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Celerion Inc.
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Parexel International Corporation
        9.8.1    Company Overview
        9.8.2    Financial Analysis
    9.9    Others
10    Industry Events and Developments

Key Questions Answered in the Report

In 2020, the Asia Pacific drug development market attained a value of nearly USD 38.23 billion.

The market is projected to grow at a CAGR of 7.1% between 2021 and 2026.

The major drivers of the industry include rising population, substantial opportunities for business expansion, lower costs in Asia and improving registration processes.

The constant growth of the pharmaceutical market, coupled with the saturated growth rates in established markets, is expected to be a key trend guiding the growth of the industry.

The types of drug development available are in house and outsourced.

Drug development can have different process steps like process research development, formulation, analytical and stability studies, drug metabolism and pharmacokinetics (DMPK), safety assessment (toxicology), regulatory compliance and packaging.

Oncology, inflammation and immunology, cardiology, and neuroscience, amongst others are some therapeutic areas for the drug development market.

The leading players in this market are Samsung BioLogics, WuXi Biologics, Celltrion Inc., PT Kalbe Farma Tbk, Eurofins Advinus, Covance Inc., Celerion Inc., and Parexel International Corporation, amongst others.

Analyst Review

The Asia Pacific drug development market attained a value of USD 38.23 billion in 2020, driven by the substantial opportunities for business expansion and the lower costs in Asia and improving registration processes. The market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 7.1%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on the mode of deployment, the drug development market can be segmented into in house and outsourced. By process step, the industry can be divided into process research development, formulation, analytical and stability studies, drug metabolism and pharmacokinetics (DMPK), safety assessment (Toxicology), regulatory compliance and packaging. Oncology, inflammation and immunology, cardiology, and neuroscience, amongst others are some therapeutic areas for the drug development market. The key players in the above industry include Samsung BioLogics, WuXi Biologics, Celltrion Inc., PT Kalbe Farma Tbk, Eurofins Advinus, Covance Inc., Celerion Inc., and Parexel International Corporation, amongst others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

United States Compounding Pharmacies Market Report and Forecast 2021-2026


Global Anaesthesia Drugs Market Report and Forecast 2021-2026


United States HIV Drugs Market Report and Forecast 2021-2026


Global Parkinson’s Disease Drugs Market Report and Forecast 2021-2026


Global Nootropics Market Report and Forecast 2021-2026


NEWSLETTER